Methods for purifying pertussis toxin and peptides useful therefor

Details for Australian Patent Application No. 2004292547 (hide)

Owner Sanofi Pasteur, Inc.

Inventors Schneider, Eberhard; Wagner, Peter; Jungbluth, Andreas

Agent Spruson & Ferguson

Pub. Number AU-B-2004292547

PCT Pub. Number WO2005/051985

Priority 60/523,881 20.11.03 US

Filing date 18 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 22 December 2011

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/235 (2006.01) Peptides having more than 20 amino acids

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/547 (2006.01) Investigating or analysing materials by specific methods not covered by groups

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051985 Priority application(s): WO2005/051985

22 December 2011 Application Accepted

  Published as AU-B-2004292547

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004292554-Anti-IGFR1 antibody therapeutic combinations

2004292546-Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain